Israel vs Sri Lanka: HIV-positive TB patients on ART (antiretroviral therapy)
Israel
100.0%
in 2024
Sri Lanka
100.0%
in 2024
Israel rank
1st
Sri Lanka rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Israel
- Sri Lanka
How they compare
Israel currently reports 100.0% against 100.0% in Sri Lanka, a difference of 0.0%.
The two have swapped places 3 times across 10 shared years of data; in 2015 it was Israel ahead.
Israel ranks 1st and Sri Lanka ranks 1st of 144 countries.
Israel has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Israel | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 84.6% | 15.4% | Israel |
| 2020s | 98.2% | 67.0% | 31.2% | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Israel or Sri Lanka?
- Israel, at 100.0% against 100.0% in Sri Lanka as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Israel and Sri Lanka?
- 0.0%, with Israel ahead.
- How many years of comparable data are there for Israel and Sri Lanka?
- 10 years are reported by both, from 2015 to 2024.
- How do Israel and Sri Lanka rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Israel ranks 1st and Sri Lanka ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.